Table 2.

Distribution of clinical syndromes and outcomes among case patients admitted during the neonatal period

SyndromeG6PD normal boys and girls (n = 526)G6PD c.202T heterozygous girls (n = 88)PG6PD c.202T homozygous girls and hemizygous boys (n = 134)P
Clinical, laboratory, and demographic features      
 Clinical jaundice, n (%) 157 (29.9) 40 (45.5) .004 81 (60.5) <.0001 
 Bacteremia,* n (%) 34 (6.5) 9 (10.2) .20 7 (5.2) .59 
 Mean Hb level (95% CI), g/L 146 (143-149) 143 (136-150) .49 138 (133-143) .0086 
 Anemia (Hb <110 g/L), n/N (%) 63/512 (12.3) 13/85 (15.3) .44 19/127 (15.0) .42 
 Severe anemia (Hb <80 g/L), n/N (%) 14/512 (2.7) 1/85 (1.2) .40 2/127 (1.6) .45 
 Median bilirubin (IQR), μmol/L 82.5 (37-191) 223 (66-319) .0001 239 (96-390) <.0001 
 Mean Hb level in those with jaundice (95% CI), g/L 148 (142-153) 149 (139-159) .82 141 (134-147) .12 
 Median weight overall (IQR), kg 2.7 (2.1-3.2) 2.8 (2.2-3.1) .80 2.7 (2.0-3.2) .92 
 Median weight in those with jaundice (IQR), kg 2.7 (2.2-3.1) 2.7 (3.4-3.0) .91 2.8 (2.4-3.2) .12 
 Median age (IQR), d 2 (0-9) 4 (0-9) .23 4 (1-7) .60 
 Median age in those with jaundice (IQR), d 5 (2-8) 4.5 (3-7.5) .71 5 (3-7) .97 
Outcome      
 Median duration of admission (IQR), d 5 (3-8) 6 (3-8.5) .08 6 (3-10) .036 
 Transfused, n (%) 25 (4.8) 11 (12.5) .004 28 (20.9) <.0001 
 Died, n (%) 118 (22.4) 15 (17.1) .26 32 (23.9) .72 
SyndromeG6PD normal boys and girls (n = 526)G6PD c.202T heterozygous girls (n = 88)PG6PD c.202T homozygous girls and hemizygous boys (n = 134)P
Clinical, laboratory, and demographic features      
 Clinical jaundice, n (%) 157 (29.9) 40 (45.5) .004 81 (60.5) <.0001 
 Bacteremia,* n (%) 34 (6.5) 9 (10.2) .20 7 (5.2) .59 
 Mean Hb level (95% CI), g/L 146 (143-149) 143 (136-150) .49 138 (133-143) .0086 
 Anemia (Hb <110 g/L), n/N (%) 63/512 (12.3) 13/85 (15.3) .44 19/127 (15.0) .42 
 Severe anemia (Hb <80 g/L), n/N (%) 14/512 (2.7) 1/85 (1.2) .40 2/127 (1.6) .45 
 Median bilirubin (IQR), μmol/L 82.5 (37-191) 223 (66-319) .0001 239 (96-390) <.0001 
 Mean Hb level in those with jaundice (95% CI), g/L 148 (142-153) 149 (139-159) .82 141 (134-147) .12 
 Median weight overall (IQR), kg 2.7 (2.1-3.2) 2.8 (2.2-3.1) .80 2.7 (2.0-3.2) .92 
 Median weight in those with jaundice (IQR), kg 2.7 (2.2-3.1) 2.7 (3.4-3.0) .91 2.8 (2.4-3.2) .12 
 Median age (IQR), d 2 (0-9) 4 (0-9) .23 4 (1-7) .60 
 Median age in those with jaundice (IQR), d 5 (2-8) 4.5 (3-7.5) .71 5 (3-7) .97 
Outcome      
 Median duration of admission (IQR), d 5 (3-8) 6 (3-8.5) .08 6 (3-10) .036 
 Transfused, n (%) 25 (4.8) 11 (12.5) .004 28 (20.9) <.0001 
 Died, n (%) 118 (22.4) 15 (17.1) .26 32 (23.9) .72 
*

Bacteremia was caused by the following organisms (n): Acinetobacter spp (4), Aeromonas spp (1), Enterobacter spp (8), Escherichia coli (6), Haemophilus influenzae (1), Klebsiella pneumoniae (2), Pseudomonas aeruginosa (3), Salmonella spp (3), Staphylococcus aureus (5), β-hemolytic Streptococcus (7), Streptococcus pneumoniae (7), Vibrio cholera (3). No independent association was seen between sex and any parameter individually.

Plasma bilirubin levels at admission in children with visible jaundice. Denominators are shown in cases where data were missing.

Close Modal

or Create an Account

Close Modal
Close Modal